School of Medicine
Revisiting 9/11, 25 Years Later
2 UConn Health physicians share their recollection of being part of the response to the World Trade Center site Sept. 11, 2001
Thriving Student Research Highlighted During Orientation Week
The 43rd Annual Graduate Student Research Day honored professors in immunology and showed off the diversity of biomedical research at UConn's School of Medicine.
Can Ketones Help Us Age Better?
UConn Health study looks at extending health span.
UConn Health Minute: Future of Heart Care
The future of heart care is being shaped by innovations that are improving patient outcomes. In this UConn Health Minute, cardiothoracic surgeon Michael Siegenthaler describes how technological advances are helping transform the way complex heart conditions are treated.
CT Occupational Disease Report is Accompanied by New Prevention Guide for the Workplace
Labor Day release of annual report prepared by UConn School of Medicine highlights reported occupational illness trends and gives workplace safety and health committees practical tools for prevention
‘Healthy Rounds’: Great Strides in Cancer Treatment
Dr. Margaret Callahan, chief of UConn Health’s Division of Hematology and Oncology, joins Dr. Anthony Alessi’s podcast
Professor Sir Cato T. Laurencin of UConn Inducted into the Black Inventors Hall of Fame
The honor recognizes Laurencin’s pioneering inventions and research in regenerative engineering.
CT AHEC’s Healthcare Workforce Interagency Symposium Emphasizes a Unified Strategy and Financial Incentives, hosted by CT SLRP
The Connecticut Area Health Education Center (CT AHEC), based at UConn Health, has long played a leading role in strengthening the healthcare workforce pipeline.
The 4-1-1 on the Impact of Lowering Federal Student Loan Limits for Healthcare Workforce Students
The Public Issues Council is made up of faculty at UConn School of Medicine as well as community partners. This Q & A article is the first in a series by faculty aiming to raise awareness to the public of the impact of various important public health topics such as new federal student loan caps.
A New Chapter for Families Living With GSDIa: From Pioneering Research to FDA Approval
U.S. Food and Drug Administration approved GENGLYCOS, a one-time gene therapy for adults and pediatric patients ages 8 and older with GSDIa and the first drug approved for this disease.